CAS Establishes Annual Production System of 1 Million Units at China Plant... Expands High Value-Added Business
Continuous Investment in Production Facilities with a Goal of Building an Annual Production System for One Million Units
Business Diversification from Electronic Scales to Healthcare and Industrial Products
To mark the 14th anniversary of the establishment of its manufacturing plant in Zhejiang Province, China, CAS is significantly strengthening its production capacity by investing in automation equipment and building a direct production system. The company is now set to embark on a full-scale expansion into the global healthcare and high value-added industrial products markets. This move is interpreted as an effort to proactively respond to the continuously growing demand for digital healthcare and regulatory changes in global markets, thereby solidifying its future growth drivers.
As demand for preventive health management increases, the digital healthcare market—including body composition analyzers and smart health devices—continues to grow. CAS announced plans to expand its related businesses by enhancing its manufacturing competitiveness and supply capabilities, leveraging its production base in China.
The manufacturing plant in Zhejiang Province, established in 2012, has continued to expand its production capacity and innovate its manufacturing processes. It is now operated as a production facility covering approximately 16,000 pyeong. The plant produces electronic scales, industrial weighing systems, and load cells, which are supplied to global markets.
This year, CAS is focusing on strengthening its smart manufacturing capabilities through investments in automation equipment and improvements to its production processes. Based on these efforts, the company has established an annual production system capable of producing one million units and is expanding its production infrastructure to meet rising global demand.
The company is concentrating on moving beyond its traditional weighing instrument-focused business model to increase the proportion of healthcare and high value-added industrial products. Leveraging its precision measurement technology, CAS is expanding its business areas into the healthcare solutions sector.
The internalization of manufacturing infrastructure at CAS is regarded as a key driver for both establishing a foothold in the healthcare business and enhancing cost competitiveness.
In particular, CAS is expanding its product lineup—centered on its integrated healthcare brand "nBody"—to include body composition analyzers, medical devices, and smart health devices. The company is also working to advance its business structure by linking its R&D capabilities with its production infrastructure.
Additionally, CAS is accelerating the shift from an OEM-focused product sales structure to a direct production system. By integrating the entire process from product development and production to quality control at its manufacturing facility in China, the company aims to enhance cost competitiveness and ensure quality stability.
To this end, CAS is investing approximately 5 million yuan (about 1 billion KRW) in equipment at its Zhejiang plant this year. The company plans to improve efficiency by establishing automated production and smart manufacturing systems, as well as strengthen its quality management system to ensure a stable supply environment.
Meanwhile, China is promoting the introduction of a "calibration traceability system" to secure the reliability of weighing data. When the related regulation is implemented in 2027, commercial scales in China will be required to meet new standards, and this is expected to generate demand for product replacement.
CAS plans to respond to these market changes while simultaneously expanding its healthcare business. Its strategy is to reinforce its competitiveness in existing businesses using accumulated technology and production infrastructure in the weighing and measurement sector, while also nurturing new healthcare and industrial businesses as future growth engines.
A CAS representative stated, "The healthcare industry is a sector where not only technological strength but also stable production capability and quality management systems are crucial. We plan to strengthen our direct production system based on our Chinese manufacturing base and expand our healthcare product portfolio to aggressively target the global market."
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
The representative added, "We will extend our accumulated technology and manufacturing expertise in weighing and measurement to the healthcare sector, secure new growth engines, and establish a sustainable business structure."
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.